The global current health expenditure per capita remains highest in developed nations, with the United States leading at $14,490, followed by Switzerland at $10,860 and Norway at $9,190. Other top spenders include Luxembourg ($7,940) and Denmark ($7,890). In contrast, countries like Moldova ($347) and Thailand ($339.2) show significantly lower expenditures, reflecting varied resource allocation and healthcare efficiencies across nations.
Notable future trends to watch include the potential impact of aging populations in higher-spending countries, technological advancements in medical treatments driving costs, and healthcare reforms aimed at cost containment. Emerging economies may also see gradual increases in health expenditure driven by economic growth and investment in healthcare infrastructure.
Top countries in Current Health Expenditure Per Capita by Country
| # | 10 Countries | US Dollars | Last Year | |
|---|---|---|---|---|
| 1 | 1 United States | 14,490 | 2023 | View data |
| 2 | 2 Switzerland | 10,860 | 2023 | View data |
| 3 | 3 Norway | 9,190 | 2023 | View data |
| 4 | 4 Luxembourg | 7,940 | 2023 | View data |
| 5 | 5 Denmark | 7,890 | 2023 | View data |
| 6 | 6 Sweden | 7,350 | 2023 | View data |
| 7 | 7 Ireland | 7,100 | 2023 | View data |
| 8 | 8 Netherlands | 6,950 | 2023 | View data |
| 9 | 9 Iceland | 6,910 | 2023 | View data |
| 10 | 10 Germany | 6,840 | 2023 | View data |
Latest reports
US Autoimmune Disease Market Report- Q1 2025
The US autoimmune disease market in Q1 2025 is experiencing significant shifts driven by advancements in biosimilars, biologics, and innovative therapies. The focus...
China Autoimmune Disease Market Report- Q1 2025
The autoimmune disease market in China has experienced substantial growth in the first quarter of 2025, driven by significant advancements in biopharmaceutical developments,...
Japan Autoimmune Disease Market Report- Q1 2025
The first quarter of 2025 witnessed significant developments in the autoimmune disease market in Japan, driven by technological advancements and strategic collaborations that...
Germany Autoimmune Disease Market Report- Q4 2024
The fourth quarter of 2024 marked a significant period for the autoimmune disease market in Germany, driven by advancements in treatment options and...
UK Autoimmune Disease Market Report- Q1 2025
The first quarter of 2025 has seen significant developments in the Autoimmune Disease UK market, driven by advancements in personalized medicine, increasing prevalence...
South Korea Autoimmune Disease Market Report- Q1 2025
The first quarter of 2025 marks a pivotal period for the Autoimmune Disease Market in South Korea, characterized by significant economic, technological, and...